These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 18717985)

  • 1. Comparison of prognostic gene expression signatures for breast cancer.
    Haibe-Kains B; Desmedt C; Piette F; Buyse M; Cardoso F; Van't Veer L; Piccart M; Bontempi G; Sotiriou C
    BMC Genomics; 2008 Aug; 9():394. PubMed ID: 18717985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature.
    Tutt A; Wang A; Rowland C; Gillett C; Lau K; Chew K; Dai H; Kwok S; Ryder K; Shu H; Springall R; Cane P; McCallie B; Kam-Morgan L; Anderson S; Buerger H; Gray J; Bennington J; Esserman L; Hastie T; Broder S; Sninsky J; Brandt B; Waldman F
    BMC Cancer; 2008 Nov; 8():339. PubMed ID: 19025599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of a 92-probe signature in breast cancer.
    Akter S; Choi TG; Nguyen MN; Matondo A; Kim JH; Jo YH; Jo A; Shahid M; Jun DY; Yoo JY; Nguyen NN; Seo SW; Ali L; Lee JS; Yoon KS; Choe W; Kang I; Ha J; Kim J; Kim SS
    Oncotarget; 2015 Jun; 6(17):15662-80. PubMed ID: 25883221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series.
    Desmedt C; Piette F; Loi S; Wang Y; Lallemand F; Haibe-Kains B; Viale G; Delorenzi M; Zhang Y; d'Assignies MS; Bergh J; Lidereau R; Ellis P; Harris AL; Klijn JG; Foekens JA; Cardoso F; Piccart MJ; Buyse M; Sotiriou C;
    Clin Cancer Res; 2007 Jun; 13(11):3207-14. PubMed ID: 17545524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients.
    Bertucci F; Finetti P; Roche H; Le Doussal JM; Marisa L; Martin AL; Lacroix-Triki M; Blanc-Fournier C; Jacquemier J; Peyro-Saint-Paul H; Viens P; Sotiriou C; Birnbaum D; Penault-Llorca F
    Ann Oncol; 2013 Mar; 24(3):625-32. PubMed ID: 23117074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status.
    Zhao X; Rødland EA; Sørlie T; Vollan HK; Russnes HG; Kristensen VN; Lingjærde OC; Børresen-Dale AL
    BMC Cancer; 2014 Mar; 14():211. PubMed ID: 24645668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fuzzy logic selection as a new reliable tool to identify molecular grade signatures in breast cancer--the INNODIAG study.
    Kempowsky-Hamon T; Valle C; Lacroix-Triki M; Hedjazi L; Trouilh L; Lamarre S; Labourdette D; Roger L; Mhamdi L; Dalenc F; Filleron T; Favre G; François JM; Le Lann MV; Anton-Leberre V
    BMC Med Genomics; 2015 Feb; 8():3. PubMed ID: 25888889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1-3 positive lymph nodes in an independent validation study.
    Mook S; Schmidt MK; Viale G; Pruneri G; Eekhout I; Floore A; Glas AM; Bogaerts J; Cardoso F; Piccart-Gebhart MJ; Rutgers ET; Van't Veer LJ;
    Breast Cancer Res Treat; 2009 Jul; 116(2):295-302. PubMed ID: 18661261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures.
    Fan C; Prat A; Parker JS; Liu Y; Carey LA; Troester MA; Perou CM
    BMC Med Genomics; 2011 Jan; 4():3. PubMed ID: 21214954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based molecular prognosis of breast cancer by transcriptional profiling.
    Ma Y; Qian Y; Wei L; Abraham J; Shi X; Castranova V; Harner EJ; Flynn DC; Guo L
    Clin Cancer Res; 2007 Apr; 13(7):2014-22. PubMed ID: 17404081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene modules associated with breast cancer distant metastasis-free survival in the PAM50 molecular subtypes.
    Liu R; Zhang W; Liu ZQ; Zhou HH
    Oncotarget; 2016 Apr; 7(16):21686-98. PubMed ID: 26934123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of 70-gene prognosis signature in node-negative breast cancer.
    Bueno-de-Mesquita JM; Linn SC; Keijzer R; Wesseling J; Nuyten DS; van Krimpen C; Meijers C; de Graaf PW; Bos MM; Hart AA; Rutgers EJ; Peterse JL; Halfwerk H; de Groot R; Pronk A; Floore AN; Glas AM; Van't Veer LJ; van de Vijver MJ
    Breast Cancer Res Treat; 2009 Oct; 117(3):483-95. PubMed ID: 18819002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-level gene expression signatures, but not binary, outperform Ki67 for the long term prognostication of breast cancer patients.
    Tobin NP; Lindström LS; Carlson JW; Bjöhle J; Bergh J; Wennmalm K
    Mol Oncol; 2014 May; 8(3):741-52. PubMed ID: 24630985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome.
    Habermann JK; Doering J; Hautaniemi S; Roblick UJ; Bündgen NK; Nicorici D; Kronenwett U; Rathnagiriswaran S; Mettu RK; Ma Y; Krüger S; Bruch HP; Auer G; Guo NL; Ried T
    Int J Cancer; 2009 Apr; 124(7):1552-64. PubMed ID: 19101988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers.
    Liu D
    Breast Cancer Res Treat; 2020 Aug; 183(1):95-105. PubMed ID: 32601968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
    Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data.
    Shen R; Ghosh D; Chinnaiyan AM
    BMC Genomics; 2004 Dec; 5(1):94. PubMed ID: 15598354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.
    Acharya CR; Hsu DS; Anders CK; Anguiano A; Salter KH; Walters KS; Redman RC; Tuchman SA; Moylan CA; Mukherjee S; Barry WT; Dressman HK; Ginsburg GS; Marcom KP; Garman KS; Lyman GH; Nevins JR; Potti A
    JAMA; 2008 Apr; 299(13):1574-87. PubMed ID: 18387932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gene-expression signature as a predictor of survival in breast cancer.
    van de Vijver MJ; He YD; van't Veer LJ; Dai H; Hart AA; Voskuil DW; Schreiber GJ; Peterse JL; Roberts C; Marton MJ; Parrish M; Atsma D; Witteveen A; Glas A; Delahaye L; van der Velde T; Bartelink H; Rodenhuis S; Rutgers ET; Friend SH; Bernards R
    N Engl J Med; 2002 Dec; 347(25):1999-2009. PubMed ID: 12490681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer.
    Chanrion M; Negre V; Fontaine H; Salvetat N; Bibeau F; Mac Grogan G; Mauriac L; Katsaros D; Molina F; Theillet C; Darbon JM
    Clin Cancer Res; 2008 Mar; 14(6):1744-52. PubMed ID: 18347175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.